Tony has been in the ion channel field for over 25 years across academia and industry and is widely published. He received his PhD from the University of Dundee (UK) characterising sodium channels of DRG neurons related to pain using the patch-clamp technique. He then studied hippocampal synaptic plasticity at Trinity College Dublin (Ireland), before continuing sodium channel research with Stephen Waxman at Yale University (USA).

Subsequently, Tony co-ordinated ion channel contracts at NeuroSolutions Ltd (UK) for clients in the biotechnology and pharmaceutical industries before moving to AstraZeneca (Sweden) to work on preclinical pain targets, where he was the lead biologist for a number of ion channel programmes.

Tony returned to the UK working on ion channel screening projects and translational assays with external parties at Xention Ltd (UK), before becoming a founding team member at Metrion.

His responsibilities include leading the team on a FTE-based collaborative drug discovery project with a pharma client and leading neuroscience activities across the company.